In the ever-watchful eyes of economists, investors, and everyday consumers, the latest US CPI December 2025 data released by the Bureau of Labor Statistics on January 13, 2026, paints a picture of inflation that’s cooling but far from dormant. The […]
AMD stock has sparked renewed investor interest in late December 2025, climbing 3.2% to close at $162.50 on December 26 following reports that the incoming Trump administration is poised to negotiate a deal allowing AMD to resume sales of its
Novo Nordisk A/S (NYSE: NVO) shares rocketed more than 9% in premarket trading on December 23, 2025, extending gains after the U.S. Food and Drug Administration approved an oral version of the company’s blockbuster Wegovy obesity treatment, marking the first-ever
The U.S. Bureau of Labor Statistics released its November 2025 Consumer Price Index (CPI) report on December 18, 2025, revealing an annual inflation rate of 3.1%, the highest since May 2024 and a tick above economists’ expectations of 3.0%. The
The Centers for Medicare & Medicaid Services announced on November 14, 2025, that Medicare premiums and deductibles will increase for 2026, with the standard Part B monthly premium rising to $202.90, up $17.90 from the 2025 level of $185.00. This
Regulatory pressures have never been fiercer, with global fines for non-compliance surpassing $15 billion in the first three quarters alone, according to PwC’s latest audit. From GDPR violations costing Meta $1.2 billion to SEC penalties hitting $500 million for crypto
Portable mortgages are gaining traction in 2025 as homebuyers face persistent high interest rates and a challenging housing market, with major lenders like Wells Fargo, Chase, and Rocket Mortgage introducing new products that allow borrowers to transfer their existing loan
The Federal Reserve announced a 25 basis point cut to its benchmark interest rate on October 29, 2025, lowering the federal funds rate to a target range of 3.75% to 4.00%. This Federal Reserve interest rate cuts 2025 move marks
The intersections of policy, pharma, and markets—from the Affordable Care Act’s rollout to the Ozempic supply chain saga—few announcements blend political theater with tangible relief like the Trump administration’s latest salvo on drug prices. On September 30, 2025, President Donald
he pulse of macroeconomic indicators from Federal Reserve boardrooms to Wall Street trading floors, the August 2025 PCE inflation report lands like a measured exhale in a room full of held breaths. Released on September 26, 2025, by the Bureau
